Article Details

New Exacerbation Data Improves Prospects For AstraZeneca's Airsupra - Scrip - Citeline

Retrieved on: 2024-10-07 15:55:28

Tags for this article:

Click the tags to see associated articles and topics

New Exacerbation Data Improves Prospects For AstraZeneca's Airsupra - Scrip - Citeline. View article details on hiswai:

Excerpt

The Avillion-partnered treatment has succeeded in the BATURA trial, adding to the body of evidence supporting Airsupra as a first-in-class rescue ...

Article found on: scrip.citeline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up